Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) announced its financial results for the first quarter of 2025, reporting a decrease in both net sales and net income compared to …
Omega Flex Reports First Quarter 2025 Earnings Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer, will represent the company at the Citizens Life Sciences Conference …
Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is set to showcase critical new findings on resmetirom, its liver-targeted thyroid hormone receptor (THR)-β agonist, at the European Association for the …
Madrigal Pharmaceuticals to Present Breakthrough Resmetirom Data at EASL Congress 2025 Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) will highlight its pioneering modifier gene therapy platform at two major industry events in May 2025. The company will present its clinical advancements …
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has named Jesse Hall, M.D., as its new Chief Medical Officer. Dr. Hall brings decades of expertise in medical and clinical development, …
Aclaris Therapeutics Welcomes Dr. Jesse Hall as Chief Medical Officer Read More
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK) announced first-quarter 2025 results, reporting net income of $2.4 million, slightly below the $2.7 million earned during the same period in 2024. Despite …
Meridian Corporation Reports Q1 2025 Earnings, Declares Quarterly Dividend Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced that an abstract presenting groundbreaking data on the prevalence and annual incidence of lymphatic malformations (LMs) in the U.S. has been …
Palvella Therapeutics to Present Key Findings on Lymphatic Malformations at Dermatology Conference Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP) has unveiled its 2025 Micropayment Trends Report, shedding light on how cashless payments now dominate self-service transactions. The report, based on data from …
Cashless Payments Dominate Self-Service Retail, Cantaloupe Report Finds Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has secured its fifth U.S. patent for QTORIN™ 3.9% rapamycin anhydrous gel, reinforcing its position in the development of treatments for rare …
Palvella Therapeutics Secures New U.S. Patent for QTORIN Rapamycin Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ATI-052, a bispecific …
Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical Trial Read More